Proteomics Diabetes, Obesity, And Endocrine, Digestive, Kidney, Urologic, And Hematologic Diseases (R01) | Apply Online

Opportunity Summary:

This grant opportunity, titled "Proteomics Diabetes, Obesity, And Endocrine, Digestive, Kidney, Urologic, And Hematologic Diseases (R01)" (Funding Opportunity Number PA 07 016), is a National Institutes of Health (NIH) program run through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It supports research projects that use proteomics to deepen understanding of diseases and normal biology across a wide set of NIDDK-related systems, including diabetes and obesity; endocrine and metabolic disorders; nutrition-related biology; and diseases affecting the gastrointestinal (alimentary) tract, exocrine pancreas, liver, kidneys, and parts of the urologic system such as the bladder and prostate. The central theme is using modern protein-focused approaches to map what proteins are present, how much of each protein is present, how proteins are modified after they are made, and how proteins interact with each other in biologically meaningful settings like cells, tissues, and whole organ systems.

Scientifically, the FOA emphasizes three main types of proteomics objectives. First, it encourages studies that identify and quantitatively measure protein expression patterns, meaning projects that profile protein abundance and compare patterns across conditions such as healthy versus diseased tissue, different disease stages, or responses to interventions. Second, it highlights post-translational modifications (PTMs), which are chemical changes to proteins after they are produced (for example phosphorylation, glycosylation, acetylation, ubiquitination, and others) that often control protein activity, stability, localization, and signaling. Third, it seeks work on protein-protein interactions, reflecting the idea that proteins typically function in complexes and pathways rather than in isolation, and that mapping interaction networks can reveal mechanisms driving pathophysiology. Across these areas, the expectation is that applicants will connect proteomic findings to meaningful biological or disease questions relevant to NIDDK mission areas, rather than generating protein lists without clear interpretive value.

In addition to applying established proteomics methods to high-impact questions, the announcement also welcomes the development and improvement of innovative proteomic technologies, as long as those advances are demonstrated through application to relevant endocrine, gastrointestinal, liver, kidney, bladder, or prostate biology and disease mechanisms. In practice, that means technology development is encouraged when it is clearly anchored in solving specific measurement challenges (such as sensitivity, dynamic range, spatial or cell-type resolution, throughput, reproducibility, or improved quantitation of PTMs and complexes) that matter for studying these tissues and disease processes. The FOA frames this as a way to accelerate progress in understanding disease pathways by improving the tools available to measure proteins and protein dynamics in complex biological systems.

The funding mechanism is the NIH Research Project Grant (R01), which is intended for mature, hypothesis-driven or well-justified research programs with a substantial scope. The FOA notes it runs in parallel with a separate announcement of the same scientific scope that uses the R21 mechanism (PA 06 185), which is typically aimed at earlier-stage, exploratory, or high-risk/high-reward projects. For applicants, the practical takeaway is that this R01 opportunity is the main track for full-scale projects where preliminary data and a clear, feasible plan for a multi-year research effort are expected.

The program does not specify a fixed budget cap or a fixed project period in the summary provided, because NIDDK anticipates that award size and duration will vary depending on the nature and scope of the proposed work. Likewise, the anticipated number of awards and total dollars are not preset in the description; they depend on factors like the number of applications received, their scientific quality, their requested durations, and their proposed costs. The announcement also states that awards can be renewed by competing for additional project periods, which aligns with standard NIH practice for R01 grants where competitive renewals are possible if progress and future plans justify continued support.

Eligibility is broad and includes many types of domestic organizations, such as public and private institutions of higher education, nonprofits (including both 501(c)(3) and other nonprofit entities), for-profit organizations (including small businesses and other for-profit entities), state and local governments, tribal governments and tribal organizations, public housing authorities/Indian housing authorities, independent school districts, and special district governments. The announcement explicitly states that foreign institutions are eligible to apply, that eligible federal agencies may apply, and that faith-based or community-based organizations may also apply, which signals an inclusive approach as long as applicants can meet NIH grant requirements and propose scientifically competitive research. There is no cost sharing or matching requirement for this opportunity.

Administratively, the opportunity is categorized as a discretionary grant within the Health and Food/Nutrition-related activity area and is associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). The posting date listed is November 20, 2006, with multiple receipt dates and multiple closing dates referenced, meaning applications were accepted on recurring NIH submission cycles during the active period of the announcement. The archived date is April 5, 2009, indicating the specific FOA version is no longer active, though similar NIDDK proteomics opportunities may exist under newer announcements. The full announcement link provided is http://grants.nih.gov/grants/guide/pa-files/PA-07-016.html, and NIH Office of Extramural Research (OER) contact information is included for technical issues accessing the notice.

Overall, this FOA is aimed at supporting rigorous proteomics-driven research that can clarify disease mechanisms, identify key protein changes and interaction networks, and improve the ability to measure proteins and their modifications in NIDDK-relevant tissues and diseases, using the R01 format for substantial, multi-year projects.

Browse more business programs for Diabetes Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01)

Previous opportunity: Molecular genetics of drug addiction and related co morbidities (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 016

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 016) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 016", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.